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A C C E P T E D M A N U S C R I P T INTRODUCTION
There is wide variability in survival among hospitals caring for patients after resuscitation from out of hospital cardiac arrest (OHCA). OHCA is common, yet survival outcomes are poor, with substantial regional and international variation. [1] [2] [3] [4] [5] Survival from OHCA ranges from 8-16. 1%. [6] Measures to maximise favourable neurological outcomes are a research priority for both patients and clinicians. [7] Post-resuscitation care, including percutaneous coronary intervention (PCI) and targeted temperature measurement (TTM), is an important component to achieve good neurological outcome. [8, 9] In most countries, post resuscitation care is not regionalized to specialised hospitals. [10] There is wide variation among hospitals in the availability and type of post resuscitation care, as well as clinical outcomes. [11, 12] Patients with other time-sensitive emergencies (e.g. trauma, acute myocardial infarction and stroke services) are often triaged to centres which offer speciality services and greater provider experience. [13] [14] [15] [16] Such centralised specialist services may improve the provision of targeted post-resuscitation care and offer similar benefits and improve patient outcomes after cardiac arrest.
A C C E P T E D M A N U S C R I P T
The International Liaison Committee on Resuscitation (ILCOR) last considered the evidence on this topic in 2015 and concluded that specialist cardiac arrest centres (CACs) may be effective despite a lack of high quality data to support their implementation. [17] Previous observational studies have reported an association between transport to CAC and survival to hospital discharge, but there is inconsistency in the hospital factors that are related to optimal patient outcomes. Whilst most experts agree that a CAC should include a 24-hour cardiac catheterisation laboratory, targeted temperature management, and neurological services that offer electrophysiological modalities for monitoring and prognostication, discrepancies remain in the definition of services that constitute a specialist CAC. [18] The objective of this systematic review was to evaluate outcomes of adults with attempted OHCA resuscitation after care in a specialized cardiac arrest centre compared with care in an institute not designated as a specialized cardiac arrest centre.
METHODS
The protocol for this systematic review was registered with PROSPERO (CRD 42018093369) on 12 th April 2018. Reporting of the systematic review was in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. [19] The review was commissioned by ILCOR.
Search strategy and selection criteria
Bibliographic databases (Embase, MEDLINE and the Cochrane Library (CENTRAL)) were searched from inception to February 2018 using a combination of index terms and key words relating to the population, intervention and comparator. The search strategy was developed in conjunction with information specialists at St Michael's Hospital Health Sciences Library (see Supplementary Materials Appendix A for sample search strategy). Reference lists of relevant articles were checked, and clinical trial registers (www.clinicaltrials.gov, www.isrctn.com and http://www.who.int/ictrp/en/) were searched to identify on-going trials. (Supplementary Materials Appendix B) Endnote 8 (Thomson Reuters) was used to store records and facilitate screening. The search was repeated on 1 st August 2018 to identify any additional studies published during the review process.
Study selection
Studies were eligible for inclusion if they met the following pre-defined criteria: 1) Population: Adults with attempted resuscitation after non-traumatic in-hospital or out-ofhospital cardiac arrest.
2) Intervention and Comparator: Care at a specialised cardiac arrest centre compared with care in a healthcare facility not designated as a specialised cardiac arrest centre 3) Outcomes: Primary outcomes were: survival at 30 days with favourable neurological outcome (defined as Cerebral Performance Category (CPC) 1 or 2, modified Rankin Scale (mRS) 0-3); and survival at hospital discharge with favourable neurological outcome (defined as CPC 1 or 2, mRS 0-3). [20, 21] Secondary outcomes were: survival at 30 days; survival at hospital discharge and return of spontaneous circulation (ROSC) after hospital admission.
4) Study Designs:
Randomised controlled trials (RCTs) and non-randomised studies (nonrandomised controlled trials, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (e.g., conference abstracts, trial protocols) were excluded. Studies reporting paediatric cardiac arrests (≤18 years old) and cardiac arrest secondary to trauma were excluded.
5) Timeframe:
All years and all languages were included as long as there was an English abstract.
Studies were selected by two reviewers (JY/TM) independently by title screening and abstract. Full text of selected studies were retrieved and reviewed by two reviewers (JY/TM) independently. Reasons for exclusion were documented. Reference lists of included studies were also screened.
Definition of Cardiac Arrest Centre
Previous literature has described CACs as institutions that have access to a 24-hour cardiac catheterisation laboratory, targeted temperature management in a critical care facility and prognostication using multimodal approach including delayed clinical examination, neuroelectrophysiological measurements and biomarkers. [22] As there is no widely accepted definition of a cardiac arrest center, we expected variation in description of healthcare institutions and terminology. [18] We accepted 'cardiac arrest centre' or 'regionalized cardiac arrest care' or 'high case volume centres' of similar description in the literature.
Data Extraction and Quality Assessment

A C C E P T E D M A N U S C R I P T
A piloted and standardised data extraction form was used to record information on study design, patient population and characteristics, sample size, description of CAC, and outcomes. Two reviewers independently (JY/TM) conducted data extraction (study design, study population, outcome measures and study quality). Any disagreement surrounding the selection of a manuscript or data extraction were resolved either by consensus or arbitration by a third reviewer (MS). Two reviewers (JY/TM) assessed risk of bias of individual studies independently, using the Cochrane Collaboration risk of bias tool [23] for randomised controlled trials and the Risk Of Bias In Non-randomised Studies -of Interventions (ROBINS-I tool) [24] for non-randomised studies. Disagreements were resolved by discussion between the two reviewers.
Data analysis and synthesis
We used meta-analyses to synthesise evidence by outcome, where this approach was not precluded.
Generic inverse variance method and random-effects model were used to compute the odds ratio (OR) and 95% confidence interval for dichotomous outcomes. [25] We measured statistical heterogeneity using the Higgins I 2 statistic. [26] We contacted study authors for additional data when it was directly relevant to our outcomes of interest. For observational studies where more than one type of analysis was reported, we preferentially used adjusted or matched case analyses, over unadjusted analyses in meta-analyses. Due to perceived substantial clinical heterogeneity, only effect estimates from adjusted analyses were pooled. In addition, the decision was to pool outcomes only if the effects were in the same direction.
We planned a priori subgroup analyses comparing outcomes from patients with shockable and nonshockable initial cardiac rhythm; and direct transfer versus secondary transfer to CACs. In addition, we undertook additional sensitivity analyses to test the robustness of our findings. Firstly, we assessed the impact of our hierarchical approach to selection of analysis type in observational studies by testing the use of other analyses on overall findings. Secondly, we attempted to identify the source of heterogeneity by performing post-hoc sensitivity analyses of studies that only included patients with prehospital ROSC and also studies with before-and-after study designs. [30] , one prospective study, 4 before and after studies and 16 retrospective analyses) fulfilled eligibility criteria and were included in qualitative synthesis. (Figure 1 ) Studies were conducted in Australia (n=3), North America (n=8), Europe (n-7) and South East Asia (n=4). The kappa value for identifying studies during initial screening was 0.83. Table 1 contains characteristics of included studies.
Data from 22 OHCA studies were included in the qualitative synthesis, with data from 17 observational studies included in meta-analysis. We described but did not include 5 studies in the meta-analysis: one randomised study since it presented only pilot feasibility data (33 patients, main trial is on-going) [30] , three observational studies that only included patients who were discharged alive from hospital and reported long-term outcome data [31] [32] [33] , and one study which examined the impact of a Post Arrest Consult Team on post cardiac arrest care processes and outcomes. [34] We found no studies reporting data for in-hospital cardiac arrest patients. One study included inhospital and out-of-hospital cardiac arrest patients but outcomes were not reported separately. [32] 
Risk of bias for individual studies
One randomised controlled study reporting pilot outcomes had moderate overall risk of bias due to lack of treatment allocation. (Table 2a ) Twenty-one observational studies had either moderate (n=9) or serious (n=12) overall risk of bias. The most common sources of bias were inadequate adjustment of confounding factors, subject selection (e.g. only including survivors), outcome measurement, and missing data. There was little to no bias from result reporting or the classification of and deviation from the intervention. (Table 2b )
Certainty of evidence across studies
The overall certainty of evidence was very low across all outcomes, primarily due to risk of bias and inconsistency. GRADE summary tables are provided in Appendix C (Supplementary Materials).
Primary outcomes
Survival at 30 days with favourable neurological outcomes (critical)
Survival to 30 days with favourable neurological outcomes were reported by three studies (one retrospective cohort study and one before and after study with adjusted analyses, and one before and after study with unadjusted analyses) recruiting 46,164 patients. [35] [36] [37] (Figure 2 ) In pooled data from two studies (n=45,956) care at CACs was not associated with increased likelihood of a favourable
neurological outcomes at 30 days compared to other hospitals (OR 2.92, 95% CI 0.68 to 12.48). There was moderate to substantial heterogeneity (I 2 73%) and certainty of evidence was very low. One study reporting unadjusted data, also found no association. [37] Survival at hospital discharge with favourable neurological outcomes (critical)
Survival to hospital discharge with favourable neurologic outcome was reported by six studies. Four studies was included in meta-analysis (one retrospective cohort study and one before and after study with adjusted analyses, and two retrospective cohort studies with unadjusted analyses) recruiting a total of 30,080 patients were included in meta-analysis. [30] [31] [32] [33] In pooled data from two studies (n=3,673), care at a CAC was associated with increased likelihood of surviving to hospital discharge with favourable neurological outcome compared to other hospitals (OR 2.22 95% CI 1.74 to 2.84).
( Figure 3 ) There was no statistical heterogeneity (I 2 0%) and certainly of evidence was assessed as very low. The direction of effect in two studies reporting unadjusted data favoured care at CACs but was no longer significantly after adjusted analyses. [38, 39] Two studies using an indirect measure (discharge destination) also favoured care at CACs for this outcome. [40, 41] 
Secondary outcomes
Survival to 30 days (critical)
Survival to 30 days was reported in six studies (two retrospective cohort studies with adjusted analyses, one before and after study and three retrospective cohort studies with unadjusted analyses) recruiting a total of 45,066 patients. [33, 35, 37, [42] [43] [44] In pooled data from two studies (n=2,693) care at a CAC was associated with increased likelihood of survival to 30 days post admission (OR 2.14 95% CI 0.73 to 6.29). (Figure 4 ) There was considerable statistical heterogeneity (I 2 86%) and the certainty of evidence was assessed to be very low. Three of the four studies reporting unadjusted data for this outcome report favourable survival for patients admitted to CACs.
Three additional studies examined long-term survival of cardiac arrest patients by focusing explicitly on the outcomes of patients discharged alive from hospital, these were not included in the metaanalysis. All three studies found that CAC admission was associated with better patient survival. [28] [29] [30] .
Survival to hospital discharge (critical)
Survival to hospital discharge was reported in ten studies (three retrospective cohort studies and two before and after studies with adjusted analyses, and five retrospective analyses with unadjusted analyses) including 42780 patients. [38] [39] [40] [45] [46] [47] [48] [49] [50] Data from meta-analysis of 5 studies (n=11,662)
found care at a CAC was associated with increased likelihood of survival to hospital discharge compared to other hospitals (OR 1.85 95% CI 1.46 to 2.34). ( Figure 5 ) There was moderate statistical heterogeneity (I 2 69%) and certainty of evidence was assessed to be very low. All five studies reporting unadjusted support the association of the pooled analysis.
Return of spontaneous circulation (ROSC) post hospital admission for patients with ongoing CPR (important)
Data on ROSC post hospital admission for patients with ongoing CPR was obtained from authors of two studies (one retrospective cohort study and one before and after study with unadjusted analyses) comprising which reported post hospital admission ROSC rates in patients with ongoing CPR. [35, 36] ( Figure 6 ) Both studies reported significantly higher ROSC rates in CAC group but data was not pooled based on the lack of adjusted data.
Subgroup Analyses and sensitivity analyses
There were insufficient data to perform the pre-planned pooled subgroup analyses of subjects with shockable vs. non-shockable initial cardiac rhythm, and direct transfer vs. secondary transfer to CAC.
Eight studies [33, 36, 37, 45, [48] [49] [50] [51] reported outcomes in CAC versus non-CACs stratified by shockable or non-shockable rhythms. Data were too heterogeneous to allow for meta-analysis (Supplementary Materials Table 3 ). In patients with shockable rhythm, four studies reported improved outcomes at CACs [36, 48, 49, 51] , and three studies reported no difference [37, 45, 50] . In patients with nonshockable initial rhythms, CACs were associated with improved outcomes in one study [51] and no difference in two studies [49, 50] .
The majority of the included studies compared OHCA patients who were directly transport to a CAC to those transported to a non-CAC. Only three studies examined outcomes in OHCA patients who were transferred to a CAC from a non-CAC [33, 36, 41] . In these studies, the proportion of patients with secondary transfers were small and, although two studies [33, 41] adjusted for available confounders, there is potential for referral bias (whereby the sickest or those most likely to survive were transferred to CACs). A US study [33] reported no difference in long-term survival between primary and secondary transfers to CACs after adjusting for potential confounders (or in unadjusted 30-day survival data provided by the authors). After conducting numerous analyses to adjust for referral bias, but the study consistently reported increased long-term survival in patients cared for at CACs, with the lowest mortality seen in early transfers. An Australian study [41] reported higher (adjusted) survival in patients who were transferred directly to a CAC compared to secondary
transfers. A small subgroup analysis by Tagami [36] found no difference in survival to 30-days with favourable neurological outcome in patients between direct and secondary transfer to CACs.
Sensitivity analysis replacing adjusted analyses with unadjusted analyses were performed for the outcomes of survival to 30 days with favourable neurological outcomes, survival to hospital discharge with favourable neurological outcomes, survival to 30 days and survival to hospital discharge. These replacements made no difference to our overall findings (data not shown). We performed sensitivity analyses to explore the source of heterogeneity by firstly excluding data from studies that transported only patients with pre-hospital ROSC [38, 40, 45, 46] for two outcomes: Survival to hospital discharge with favourable outcomes (2 studies) and Survival to hospital discharge (4 studies). This did not change our overall findings but did reduce statistical heterogeneity in Survival to hospital discharge from I 2 90% to 52% (data not shown). Secondly, we performed sensitivity analyses by excluding studies of before and after design [36, 37, 48, 49] for three outcomes: Survival to hospital discharge with favourable outcome (1 study), Survival to 30 days (1 study), and Survival to hospital discharge (2 studies). The results were again similar to our main analyses (data not shown). Relevant issues include the safety and logistics of longer prehospital transport time, the risk of rearrest and other adverse events, the negative impact of transport on CPR quality, and whether to bypass a local hospital or arrange for secondary transfer after stabilization at a local hospital. [52] [53] [54] Our review did not specifically investigate the impact of transport duration on patient outcomes but did include some studies that reported transport times. Using a mathematical model, Kragholm, et al. concluded that there is survival benefit for cardiac arrest patients with prehospital ROSC to be transported to CAC even if journey time exceeds 20 minutes. [46] Similar findings were reported by Tranberg et al. who also reported that distances from arrest location to CAC was not associated with patient survival. [43] In contrast, regression analyses from Cournoyer study stated that increasing the delay from call to hospital arrival by 14.0 min would offset the potential survival benefit of being transported to a PCI-capable centre. [50] The decision whether to transport a patient and the hospital destination are likely to differ in urban, suburban, and rural settings. [55] Appropriately validated decision-making and risk prediction tools may help guide rescuers with transport and treatment decisions in future studies. [56, 57] Future clinical trials should also include the critical outcome of long term survival with favourable neurological outcomes to address this research gap. [7] There was only one pilot randomised controlled study which reported only feasibility outcomes and did not demonstrate a difference between 30-day survival (CAC 9/18 50% vs other 6/15 40%) or 30day survival with favourable neurological outcome (CAC 9/18 50% vs other 7/14 50%). [30] This study has just started recruiting. High quality evidence is needed to test the impact of CAC post cardiac arrest care on patient outcomes and address several remaining clinical knowledge gaps. For instance, specific subgroups of subjects (e.g. cardiac aetiology, shockable initial cardiac rhythm, ROSC or no ROSC prior to hospital admission) may benefit more or less from regional CAC care.
DISCUSSION
A key limitation is the general lack of consensus on what constitutes a CAC. In light of this, we accepted the study authors' definitions and descriptions of regional hospitals with a large case volume and coronary intervention capacity as a CAC. Likewise, we have not been able to substantiate or disprove these stated levels of service or other touted elements of post arrest care. We urge the Utstein writing group to consider CAC definition in the next iteration of Utstein variables for OHCA. Whilst clinical expertise and post arrest intervention should be readily available in CAC, hospital admission does not cases/year) and found both survival and neurological outcomes of cardiac arrest patients were higher in CACs regardless of volume status. [51] There was also no reported difference in outcomes by hospital volume status (2 studies in CAC [40, 45] , 1 study other hospitals [35] , 1 study across all hospitals [38] ).
Additional logistical and organization knowledge gaps remain in post cardiac arrest care. Regionalised post-cardiac arrest care is not feasible without a robust supporting network and regionalisation of medical services at the local and municipal levels. [62, 63] Fortunately, the trauma, STEMI, and stroke systems of care provide a template to establish a similar infrastructure for cardiac arrest. The success of whole system change such as those seen in major trauma systems cannot be ignored, and it needs to be highlighted that this change was not based on data from high quality randomized controlled trials but on observational data. [64] CAC services could potentially overlap with the cardiovascular and neurologic services offered at regional STEMI and stroke centres. Whilst indirect evidence established the cost effectiveness of stroke and STEMI centres, [65, 66] the cost effectiveness of specific strategies focusing on cardiac arrest patients and their potential impact on the care of other patient groups remains unknown.
The studies included in our review focused on clinical outcomes such as survival that has traditional been considered to be of critical importance. Through the work of Core Outcome Set for Cardiac Arrest, there is a clear need for future research to address outcomes that are relevant and important to patient and their family such as quality of life and organ donation. [7, 67] 
Limitations
We encountered high statistical heterogeneity in our meta-analysis and scrutinised included study characteristics for potential source of bias. Four studies [38, 40, 45, 46] included only patients with
prehospital ROSC in their analysis, possibly due to local policy and clinical practice. [68, 69] Survival from patients with no pre-hospital ROSC and requiring ongoing CPR may be better than commonly believed. [70] Before-and-after study designs used in four studies [36, 37, 48, 49] may not adequately control for changes in clinical practice. Both sets of sensitivity analyses did not adequately explain statistical heterogeneity. There was insufficient data from included studies for us to examine specifically whether there is any difference in outcomes for patients who present with shockable vs. non-shockable initial cardiac rhythm. We were also unable to conclusively assess the impact of direct transfer vs. secondary transfer to CAC. There was also no meaningful data to examine whether care at CAC has any influence on patient outcomes from in-hospital cardiac arrest compared to other hospitals.
CONCLUSIONS
Very low certainty evidence suggests that post-cardiac arrest care at cardiac arrest centres is associated with improved survival with favourable neurological outcome at hospital discharge and improved survival to hospital discharge. Care at CACs did not improve survival to 30 days with favourable neurological outcome and survival to 30 days. There remains a need of high quality data individual patient data meta-analysis and or data from randomised trials to fully elucidate the impact of CAC. 
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